Is NBIX Stock A Buy or Sell?
In this article you are going to find out whether hedge funds think Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is a good investment right now. We like to check what the smart money thinks first before...
Neurocrine Biosciences Inc (NBIX)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,397,864 | $135,942 | -23% | 0.16% |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 155,000 | $15,074 | +4% | 1.05% |
| 3. | 7,609,000 | $10,305 | 0.66% | ||
| 4. | Birchview Capital Matthew Strobeck | 80,200 | $7,799 | 4.62% | |
| 5. | Hudson Bay Capital Management Sander Gerber | 65,000 | $6,321 | -8% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.96 | 22,300 | Large Shareholder | 3,527,700 | 2011-10-12 | Filing | |
| $5.96 | 1,000 | Large Shareholder | 757,600 | 2011-10-12 | Filing | |
| $5.96 | 6,200 | Large Shareholder | 1,236,665 | 2011-10-12 | Filing | |
| $5.73 | 3,800 | Large Shareholder | 3,505,400 | 2011-10-11 | Filing | |
| $5.59 | 44,700 | Large Shareholder | 3,501,600 | 2011-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $119.95 | 600 | Officer | 32,510 | 2021-02-10 | Filing | |
| $119.96 | 1,100 | Officer | 32,510 | 2021-02-10 | Filing | |
| $116.83 | 1,623 | Officer | 104,768 | 2021-02-08 | Filing | |
| $116.83 | 1,000 | Officer | 103,306 | 2021-02-08 | Filing | |
| $116.89 | 1,070 | Officer | 102,406 | 2021-02-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 425,226 | $41,353,231 | 0.01% | |
| 2. | 21,450,000 | $28,956,213 | 0.01% | |
| 3. | 138,796 | $13,497,911 | 0.02% | |
| 4. | 118,769 | $11,550,285 | 0.08% | |
| 5. | 60,266 | $5,860,868 | 0.06% |
News See All
Is NBIX A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives...
Is Neurocrine Biosciences (NBIX) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Health Care Fund returned 11.64% (institutional...
Was The Smart Money Wrong About Neurocrine Biosciences, Inc. (NBIX)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Neurocrine Biosciences (NBIX): Hedge Funds In Wait-and-See Mode
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on...
Did Hedge Funds Make The Right Call On Neurocrine Biosciences, Inc. (NBIX)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Should You Avoid Neurocrine Biosciences, Inc. (NBIX)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW)....
Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and predicted that a US recession is imminent and US stocks will go down...
How Did Neurocrine Biosciences, Inc. (NBIX) Compare Against Top Hedge Fund Stocks in 2019?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very...
Hedge Funds Have Never Been This Bullish On Neurocrine Biosciences, Inc. (NBIX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these...
Billionaire Hedge Funds
